Symic Biomedical's Grant

Symic Biomedical raised a round of funding on August 27, 2015. Investors include National Institutes of Health.

Symic Bio is a biopharmaceutical company developing a new category of therapeutics focused on matrix biology. The Symic Bio platform of matrix-targeting biotherapeutics builds upon emerging research o…

Articles about Symic Biomedical's Grant: